1054640-96-8

Basic information

• Product Name: (S)-5-Benzyloxycarbonylamino-2-(3-ethoxycarbonylmethyl-ureido)-pentanoic acid methyl ester
• CAS NO: 1054640-96-8
• Molecular Weight: 409.439
• Mol File: 1054640-96-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-5-Benzyloxycarbonylamino-2-(3-ethoxycarbonylmethyl-ureido)-pentanoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-5-Benzyloxycarbonylamino-2-(3-ethoxycarbonylmethyl-ureido)-pentanoic acid methyl ester(1054640-96-8)
• EPA Substance Registry System: (S)-5-Benzyloxycarbonylamino-2-(3-ethoxycarbonylmethyl-ureido)-pentanoic acid methyl ester(1054640-96-8)

Safety Data

• Hazardous Substances Data: 1054640-96-8(Hazardous Substances Data)

Upstream product

• 3304-51-6 N-carboxybenzyl-L-ornithine 
• 62631-17-8 Methyl N-δ-benzyloxycarbonyl-L-ornithinate 
• 2949-22-6 Glycine ethyl ester isocyanate 

Downstream Products

• 197358-31-9 {4-[3-(1H-benzoimidazol-2-ylamino)-propyl]-2,5-dioxo-imidazolidin-1-yl}-acetic acid 
• 197358-29-5 ((S)-4-{3-[3-(2-Nitro-phenyl)-thioureido]-propyl}-2,5-dioxo-imidazolidin-1-yl)-acetic acid 
• 197358-30-8 ((S)-4-{3-[3-(2-Amino-phenyl)-thioureido]-propyl}-2,5-dioxo-imidazolidin-1-yl)-acetic acid 
• 197358-28-4 (S)-2-Benzyloxycarbonylamino-3-(2-{(S)-2,5-dioxo-4-[3-(pyrimidin-2-ylamino)-propyl]-imidazolidin-1-yl}-acetylamino)-propionic acid tert-butyl ester 
• 197358-13-7 2-benzyloxycarbonylamino-3-(2-{4-[3-(4,5-dihydro-1H-imidazol-2-ylamino)-propyl]-2,5-dioxo-imidazolidin-1-yl}-acetylamino)-propionic acid tert-butyl ester 
• 197358-32-0 3-(2-{4-[3-(1H-benzoimidazol-2-ylamino)-propyl]-2,5-dioxo-imidazolidin-1-yl}-acetylamino)-2-benzyloxycarbonylamino-propionic acid tert-butyl ester 

Relevant articles and documents

RGD mimetics containing a central hydantoin scaffold: α(v)β3 vs α(IIb)β3 selectivity requirements

The synthesis of a series of RGD mimetic α(v)β3 antagonists containing a hydantoin scaffold is shown. The results demonstrate some of the structural requirements for the design of selective α(v)β3 antagonists (vs α(IIb)β3)